Sentence examples for prior licensing from inspiring English sources

The ruling means RIM will have to pay royalties for handsets now considered to be in breach of a prior licensing agreement between the two.

Prior studies have shown that firms with satisfactory prior licensing experience and perception of high licensing benefits relative to costs have a higher propensity for in-licensing technology (Atuahene-Gima 1993).

The plaintiffs successfully resolved the lawsuit three years later, only after OFAC revised the regulations and eliminated the need for prior licensing.

Its prior license expired in May but was extended by TfL for four months as the regulator continued to deliberate over whether it should grant Uber another full five year term in the face of rising criticism against its business — including on issues such as workers' rights and public safety.

The RCT (Trainer 2000 [ 7]) was conducted prior to licensing.

Prior to licensing for AMD treatment, many people chose to have treatment with bevacizumab since without any treatment they faced rapid blindness and they preferred to accept the possibility of increased side effects with the unlicensed product.

In general, both the FDA and EMA have recognized some uncertainties relating to safety and efficacy with the novel agents; however, the FDA considered the risk to benefit balance acceptable for specific issues to be addressed with post-marketing trials, whereas the EMA demanded that further data be obtained prior to licensing.

If you have been convicted of felony crimes of dishonesty or breach of trust or any violation of Title 18 U.S.C. § 1033, you must submit a 1033 Application for Written Consent to obtain the consent of the Commissioner prior to licensing.

"The state requirements for new drivers taking driver ed prior to licensing are inconsistent and all over the map," Mr. Ulczycki said.

On Thursday, independent scientists from the Cochrane Collaboration published an analysis of all the data from the clinical trials conducted by manufacturers Roche and GlaxoSmithKline prior to licensing of the drugs, which took them over four years of negotiations to obtain.

This contribution describes the phases of psychotropic drug development, highlights some aspects of study design in the evaluation of potential treatments prior to licensing, and considers likely future challenges in this research environment.